Christopher Koh

Partner

Christopher is Deputy Head of the Corporate Mergers & Acquisitions Department at Allen & Gledhill. His areas of practice encompass mergers and acquisitions, private equity and corporate advisory work for financial institutions and public companies listed on the Singapore Exchange.

He has extensive experience in domestic and cross-border mergers and acquisitions across a broad range of industries and has acted for financial institutions, publicly listed companies, multinational corporations and private equity firms in various corporate and M&A transactions, with a focus on public takeovers, private investments in public equity and privatisations. He also advises publicly listed companies regularly on their continuing disclosure obligations under the listing rules of the Singapore Exchange.

Christopher graduated from the National University of Singapore with an LLB (Hons) degree in 1999 and obtained an LLM from Columbia University in 2002, where he graduated as a Harlan Fiske Stone Scholar.

Christopher is the Principal Examiner for the Mergers & Acquisitions section of the Corporate & Commercial Practice module of the Singapore Bar Examinations.

Christopher is recognised as a leading lawyer for Corporate/M&A by asialaw Leading Lawyers, Chambers Global, Chambers Asia-Pacific, IFLR1000, The Legal 500 Asia Pacific, Lexology Index and Asia Business Law Journal (Singapore’s Top 100 Lawyers).

Work Highlights

• Advised Rohto Pharmaceutical Co., Ltd. and Mitsui & Co., Ltd. on the S$800 million acquisition of approximately 86 per cent. of the ordinary shares in Eu Yan Sang International Ltd and the pre-conditional mandatory general offer to acquire all of its remaining ordinary shares.
• Advised Doctor Anywhere Pte. Ltd. on its approximately S$109 million acquisition (through Labrador Park Pte. Ltd.) of AsianHealthcare Specialists Limited, a multidisciplinary medical services group, by way of a voluntary conditional cash offer.
• Advised the REIT manager of SPH REIT as the offeree in relation to the approximately S$1.4 billion chain principle offer by Morgan Stanley Asia (Singapore) Pte., for and on behalf of Cuscaden Peak Pte. Ltd. (a company formed by the consortium comprising vehicles established by Hotel Properties Limited, CLA Real Estate Holdings Pte. Ltd. and Mapletree Investments Pte Ltd).
• Acted for CapitaLand Mall Trust (“CMT”) in its US$8.2 billion merger with CapitaLand Commercial Trust (“CCT”) through the acquisition by CMT of all the issued and paid-up units of CCT held by the unitholders of CCT in exchange for a combination of cash and units in CMT by way of a trust scheme of arrangement in accordance with the Singapore Code on Take-overs and Mergers.
• Advised IHH Healthcare Berhad on its approximately US$1.1 billion acquisition of a controlling stake in Fortis Healthcare Limited (“Fortis”), through a combination of primary equity infusion and secondary purchase from the shareholders of Fortis.
• Acted for J.P. Morgan in its role as the financial adviser to Global Logistic Properties (“GLP”) in the approximately S$16 billion acquisition by Nesta Investment Holdings of GLP by way of a scheme of arrangement, which was the largest Asia-Pacific private equity buyout.
• Acted for Northstar Advisors in its approximately S$331.4 million acquisition of Innovalues by way of a scheme of arrangement, which was awarded PE Deal of the Year 2017 by the Singapore Venture Capital & Private Equity Association.
• Acted for Avago Technologies in its acquisition of Broadcom for approximately US$37 billion, which was awarded “Deal of the Year” and “M&A Deal of the Year (Premium)” at the Asian Legal Business SE Asia Law Awards 2016.